Skip to main content
. Author manuscript; available in PMC: 2021 Nov 23.
Published in final edited form as: Anal Chem. 2017 Jan 4;89(2):1194–1201. doi: 10.1021/acs.analchem.6b03625

Figure 1:

Figure 1:

Overall workflow for the PRISMS screening platform including (a) creation of peptide libraries through extraction and fraction of crude extracts (b) whole-cell bioactivity screening of peptide libraries against pathogen targets of interest (c) LC-MS/MS analysis of active peptide libraries and (d) statistical modeling of LC-MS/MS datasets vs. active bioactivity regions for determination of (e) putative bioactive peptide targets.